Mesalamine Tablet, Delayed Release
Product Images NDC 72162-2231

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 72162-2231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of Mesalamine showing a benzene ring with amino (NH2), hydroxyl (OH), and carboxyl (COOH) functional groups. The image also displays the molecular formula C7H7NO3 and a molecular weight of 153.14.*

FDA Label Image

Label (Lbl721622231)

Mesalamine Delayed-Release Tablets, USP 1.2 gram, oral dosage form, shown on a label for 120 tablets. The label includes the NDC 72162-2231-2 and states the product is prescription only. The label identifies Bryant Ranch Prepack as the relabeler located in Burbank, CA, and Actavis Pharma, Inc. as the manufacturer. Storage instructions and pharmacist dispensing notes are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.